Aspira Pathlab & Diagnostics (BOM:540788) PEG Ratio: N/A (As of Aug. 08, 2026)

Aspira Pathlab & Diagnostics  (BOM:540788) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.

Aspira Pathlab & Diagnostics PEG Ratio Related Terms

The historical data trend for Aspira Pathlab & Diagnostics's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aspira Pathlab & Diagnostics PEG Ratio Chart

Aspira Pathlab & Diagnostics Annual Data
	Trend	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24	Mar25	Mar26
PEG Ratio		Get a 7-Day Free Trial					0.00	0.00	0.00	0.00	0.00

Aspira Pathlab & Diagnostics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
PEG Ratio	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

BOM:540788 vs TMO, DHR, IDXX: PEG Ratio Comparison

For the Diagnostics & Research subindustry, Aspira Pathlab & Diagnostics's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aspira Pathlab & Diagnostics PEG Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Aspira Pathlab & Diagnostics's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Aspira Pathlab & Diagnostics's PEG Ratio falls into.

Aspira Pathlab & Diagnostics PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Aspira Pathlab & Diagnostics's PEG Ratio for today is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Aspira Pathlab & Diagnostics Business Description